POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced the expansion of its Phase 2 CALMA trial for IGC-AD1 into ...

Pioneering biostatistician and infectious disease expert Dr. Elizabeth Halloran recently transitioned to emerita after a 40-year career shaping the design and analysis of vaccine trials and pandemic ...

In August 2022 the Department of Health and Human Services (HHS) issued a notice of proposed rulemaking prohibiting covered entities, which include health care providers and health plans, from ...

Blood-based markers of differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting II.

According to the Sunday Times, a former analyst at the Bank of England (BoE), which is the central bank of the United Kingdom, has written to the bank’s governor, Andrew Bailey, regarding the need to ...